Interactive Sessions

Take advantage of the 2014 GU Symposium's select interactive sessions, and join in the conversation!

Submit Your Case

The following sessions will use audience cases submitted prior to the meeting. Please submit your cases by December 23rd using the links below. 

Thursday, January 30:

4:00 PM - 5:15 PM General Session 3: Prostate Cancer—Tumor Board Audience Challenge

Friday, January 31:

7:55 AM -
9:30 AM
General Session 4: Multimodal Management of Urothelial Carcinoma



Network with colleagues at new Roundtable discussion sessions--connect at this year’s Symposium!

Roundtable discussions provide an opportunity for attendees to engage in conversations with peers on attendee chosen topics, themes, and issues in GU cancers that are important to discuss right now:

Thursday, January 30

11:30 AM
  • Timing and sequencing of combined therapy for CRPC: how we can do a better job designing clinical trials to prove the efficacy of one combination over another?
    Facilitator: Karim Fizazi, MD, PhD, of the Institut Gustave-Roussy
  • Utility, development, and deployment of clinical registries: with a national radiation oncology registry for prostate cancer underway and an AUA registry under development, discuss how to standardize these as much as possible.
    Facilitator: Daniel W. Lin, MD, of the University of Washington
  • Quantitative imaging of bone metastases in prostate cancer for prognostication, disease progression and response to treatment

Friday, January 31

12:00 PM
  • How to integrate preoperative chemotherapy with chemoradiation for bladder cancer and chemorads for T1 bladder cancer
    Facilitators: Jason Efstathiou, MD, DPhil, of Massachussetts General Hospital; Marissa Kollmeier, MD, of Memorial Sloan-Kettering Cancer Center
  • Role of adjuvant therapy in muscle invasive bladder cancer
    Facilitator: J. Alfred Witjes, MD, PhD, of Radboud University, Nijmegen Medical Center


Saturday, February 1

11:30 AM
  • Drug Development in Kidney Cancer: Looking Ahead
    Facilitator: Primo Lara, Jr., MD, of the University of California, Davis Comprehensive Cancer Center

All roundtable discussions will take place in the Yerba Buena Ballroom Foyer, located next to the Exhibits and Food Room (Salon 6)

Audience Response System

The following sessions use an audience response system (ARS), which allows attendees to use a web-enabled device to answer multiple choice questions, and compare their answers with those of other attendees and faculty.

Thursday, January 30:

4:00 PM - 5:15 PM General Session 3: Prostate Cancer - Tumor Board Audience Challenge

 Friday, January 31:

7:55 AM - 9:30 AM General Session 4: General Session 4: Multimodal Management of Urothelial Carcinoma


Electronic Q&A (eQ&A)

The following sessions use an electronic question-and-answer option (eQ&A), allowing attendees to submit their questions electronically using their web-enabled device.

Thursday, January 30:

1:00 PM - 2:45 PM Oral Abstract Session A:Prostate Cancer

Friday, January 31:

1:30 PM - 3:00 PM Oral Abstract Session B: Urothelial Carcinoma, and Penile, Urethral, and Testicular Cancers

Saturday, February 1:

9:45 AM - 11:30 AM Oral Abstract Session C: Renal Cancer

Cosponsored by